Tower Research Capital LLC (Trc) Altamira Therapeutics Ltd. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.48 - $1.66 $10,823 - $37,431
22,549 Added 22549.0%
22,649 $11,000
Q1 2022

May 12, 2022
SELL
$0.69 - $1.92 $4,594 - $12,785
-6,659 Reduced 98.52%
100 $0
Q4 2021

Feb 14, 2022
BUY
$1.28 - $2.4 $7,508 - $14,078
5,866 Added 656.89%
6,759 $12,000
Q3 2021

Nov 15, 2021
BUY
$2.01 - $3.58 $1,794 - $3,196
893 New
893 $2,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email